Lin H.-H.SHIH-JER HSULu S.-N.Chuang W.-L.Hsu C.-W.Chien R.-N.Yang S.-S.Su W.-W.Wu J.-C.Lee T.-H.Peng C.-Y.Tseng K.-C.Qin A.Huang Y.-W.PEI-JER CHEN2022-09-132022-09-1320212397-9070https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109376133&doi=10.1002%2fjgh3.12613&partnerID=40&md5=a6aa60894bce2cdbc7c73f77101b0f4fhttps://scholars.lib.ntu.edu.tw/handle/123456789/619323[SDGs]SDG3Ropeginterferon alfa-2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacyjournal article10.1002/jgh3.126132-s2.0-85109376133